Most variables did not significantly differ among the groups, including age; sex ratio; duration of diabetes; smoker proportion; hypertension; prior MI, PCI, CABG, or stroke; LVEF; clinical presentation; left main disease; multi-vessel disease; treatment strategy; FPG; LDL-C; aspirin; clopidogrel/ticagrelor; β-blocker; ACEI or ARB; CCB; nitrate; and insulin (P > 0.050). This evidence concerns the gene INS and diabetes mellitus.